Latest Garvan Institute News | Page 2

Green light for universal Covid vaccine project
Ground-breaking Australian research answers long-standing genetic mystery of why people develop rare hidden cancer
Global study identifies genes that cause sarcoma
Genes that cause rare childhood cancer revealed by Austral
Poorer health outcomes for at-risk patients with fractures
Is a vaccine for melanoma on the cards?
UNSW researchers receive more than $16m in Ideas Grants
Emerging technologies overshadowed in Senate biosecurity report
NHMRC awards Ideas Grants to Garvan researchers
Genetic link in childhood glaucoma
Why autistic children are more likely to have gut problems
Rogue immune cells linked to leukaemia are key driver of a
Tumour matrix profiling gives clues to progression of some l
New hope for Australian families carrying deadly cancer gene variant
DNA barcoding reveals cancer cells’ ability to evade imm
New research centre to bring world’s best measuring device out of lab
Ancient genomes reveal hidden history of human adaptation
World-first gene therapy clinical trial for type 1 diabetes
Clinical trial will test drug treatment for dementia
UNSW leads Australian universities, attracting $65 million in NHMRC Investigator Grants
Researchers awarded five NHMRC Investigator Grants
Patterns of underlying health issues linked to poorer outcom
Higher body temperature alters key protein in autoinflammato
New epigenetic markers for prostate cancer discovered
New $2.5m genomics project boosts precision medicine
Improving health outcomes for First Nations Australians
More inclusive genomic resource for diverse Australian commu
New $2.5m genomics project advances precision medicine
4 researchers striving to reduce impact of childhood cancer in our community
US enlists UQ to seek new ways to battle melanoma
Four Eureka Prizes awarded to UNSW researchers
Aggressive prostate cancer linked to ancestral heritage
Mapping food supply chains, nanotech cancer diagnosis, and tracking bushfire recovery winners at 2022 Eureka Prizes
NanoMSlide wins Eureka Prize 2022
4 researchers helping more people survive breast cancer
Can new technology deliver pancreatic cancer breakthrough?
Collagen key player in breast cancer metastasis
New COO for Heart Research Institute
NanoMslide is Eureka Prize finalist
Genetic clues to age-related macular degeneration revealed
Leading scientists use Genomics England data set to propose updated global guidelines to improve rare disease diagnosis
Genetic and molecular insights into dangerous tick bite-related meat allergy revealed
Clinical trial to test potential new combination therapy for aggressive breast cancer
Australian stem cell research reveals detailed genetic roadmap of glaucoma
Stem-cell models reveal glaucoma secrets
Stem cell research reveals detailed genetic roadmap of glaucoma
Rapid lab analysis informs global guidelines on Covid vaccination and treatment
EpiAxis Therapeutics appoints new chief science officer